04/09/2026
๐ง ๐๐ผ๐๐น๐ฑ ๐๐ต๐ฒ ๐น๐ฒ๐๐ฒ๐น ๐ผ๐ณ ๐ฝ๐ฒ๐ฟ๐๐ถ๐๐๐ฒ๐ป๐ ๐ฎ๐ป๐๐ถ๐ฝ๐ต๐ผ๐๐ฝ๐ต๐ผ๐น๐ถ๐ฝ๐ถ๐ฑ ๐ฎ๐ป๐๐ถ๐ฏ๐ผ๐ฑ๐ถ๐ฒ๐ ๐ต๐ฒ๐น๐ฝ ๐๐ฒ๐น๐น ๐๐ ๐บ๐ผ๐ฟ๐ฒ ๐ฎ๐ฏ๐ผ๐๐ ๐๐๐ฟ๐ผ๐ธ๐ฒ ๐ฟ๐ฒ๐ฐ๐๐ฟ๐ฟ๐ฒ๐ป๐ฐ๐ฒ?
A new study followed 47 people who had experienced a cryptogenic stroke or TIA and continued to test positive for antiphospholipid antibodies (aPLs) for at least 12 weeks.
Researchers found that recurrent ischaemic stroke was less common in people with weakly positive aPLs than in those with strongly positive aPLs.
Treatment patterns also differed: antiplatelet medicines were recommended more often in the weakly positive group, while warfarin was more commonly recommended for those with strongly positive aPLs.
Itโs an interesting finding, but the study was small, retrospective and carried out within one health system. The researchers say larger prospective studies and randomised trials are needed to better understand the best treatment approach.
๐ Read the study: https://pubmed.ncbi.nlm.nih.gov/42668533/